Why Diabetes Stock Dexcom Jumped 14.6% in February While the Market Dropped
Shares of medical device maker Dexcom, Inc. (NASDAQ: DXCM) gained 14.6% in February, according to data from S&P Global Market Intelligence.
That performance is even stronger than it might initially seem considering the S&P 500 index dropped 8.2% last month due to concerns that the novel coronavirus, COVID-19, could blunt global economic growth.
Dexcom stock is up a whopping 95.1% over the one-year period through March 5, compared to the broader market's 10.6% return over this period.
Source Fool.com
